Novorapid and alanine aminotransferase increased Patient Reports February 10, 2010

Novorapid Side Effects Report #5719408-7
Novorapid side effect was reported by a Physician from JAPAN on Apr 17, 2008. Female patient, 68 years of age, weighting 88.18 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral haemorrhage traumatic, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, BASEN, MEVALOTIN, BLADDERON. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5774851-5
Novorapid side effect was reported by a Physician from JAPAN on June 05, 2008. Female patient, 60 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal. Novorapid dosage: unknown. During the same period patient was treated with AMARYL, BASEN, SIGMART, LIPITOR, ARIMIDEX. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5712773-6
Novorapid side effect was reported by a Physician from JAPAN on Apr 11, 2008. Male patient, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, GASMOTIN, NOVORAPID CHU, NOVORAPID CHU, EUGLUCON, DAONIL, ASPIRIN, LEVEMIR. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5195435-6
Novorapid side effect was reported by a Physician from JAPAN on Dec 19, 2006. Female patient, 83 years of age, weighting 74.96 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, blood alkaline phosphatase increased, cholangitis acute, gamma-glutamyltransferase increased, gastric cancer, haemoglobin decreased, hepatic enzyme increased. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RADEN, GLORIAMIN, ATARAX, PREDONINE, HALCION. Patient was hospitalized. Patient died on 03/03/2006.


Novorapid Side Effects Report #5134384-6
Novorapid side effect was reported by a Physician from JAPAN on Oct 16, 2006. Female patient, 75 years of age, weighting 121.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, diabetic nephropathy and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis c , hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with ADALAT, DIOVAN, WYTENS, FLUITRAN, KINEDAK, JUVELA NICOTINATE, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5498695-7
Novorapid side effect was reported by a Physician from JAPAN on Oct 15, 2007. Female patient, 63 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased. Novorapid dosage: unknown. During the same period patient was treated with LIPITOR, ASPIRIN, TANATRIL, ADALAT, GLYBURIDE, MELBIN, MIGLITOL. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5157346-1
Novorapid side effect was reported by a Physician from JAPAN on Nov 15, 2006. Male patient, 51 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN R. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5166684-8
Novorapid side effect was reported by a Physician from JAPAN on Nov 15, 2006. Male patient, 51 years of age, weighting 123.5 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood glucose increased, gamma-glutamyltransferase increased. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN R, HUMALOG, MAGMITT, HUMULIN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5176365-2
Novorapid side effect was reported by a Physician from JAPAN on Nov 15, 2006. Male patient, 51 years of age, weighting 123.5 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood glucose increased, gamma-glutamyltransferase increased, liver disorder. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN R, HUMALOG, MAGMITT, HUMULIN. Patient was hospitalized. Patient recovered.


Novorapid Side Effects Report #5374473-4
Novorapid side effect was reported by a Physician from JAPAN on June 22, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.

Novorapid Side Effects Report #5832216-1
Novorapid side effect was reported by a Physician from JAPAN on July 25, 2008. Female patient, weighting 103.6 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, hyperlipidaemia, cerebral infarction, hypertension and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU, NOVOLIN N, LIPITOR, BAYASPIRIN, TANATRIL, ADALAT. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4562875-5
Novorapid side effect was reported by a Physician from on Dec 13, 2004. Male patient, 33 years of age, weighting 90.39 lb, was diagnosed with diabetes mellitus insulin-dependent, infusion site abscess and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder. Novorapid dosage: unknown. During the same period patient was treated with CEFAZOLIN, INSULIN NOVOLET R, PENFILL R CHU, HUMULIN R. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4582505-6
Novorapid side effect was reported by a Physician from on Dec 13, 2004. Male patient, 33 years of age, weighting 90.39 lb, was diagnosed with diabetes mellitus insulin-dependent, infusion site abscess and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder. Novorapid dosage: unknown. During the same period patient was treated with CEFAZOLIN, INSULIN NOVOLET R, PENFILL R CHU, HUMULIN R. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4716850-8
Novorapid side effect was reported by a Physician from JAPAN on July 07, 2005. Male patient, 28 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.


Novorapid Side Effects Report #4733239-6
Novorapid side effect was reported by a Physician from JAPAN on July 07, 2005. Male patient, 28 years of age, weighting 125.7 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest discomfort, hepatic function abnormal, thirst. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4700118-X
Novorapid side effect was reported by a Physician from on Nov 26, 2004. Male patient, 77 years of age, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLOG, FLUTRIA, RENIVACE, KINEDAK. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4552837-6
Novorapid side effect was reported by a Physician from on Dec 01, 2004. Female patient, 66 years of age, weighting 85.98 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #5962146-6
Novorapid side effect was reported by a Consumer or non-health professional from JAPAN on Nov 12, 2008. Male patient, 62 years of age, weighting 127.9 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, liver disorder, pericardial effusion, pleural effusion, thirst, weight decreased, weight increased. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4597690-X
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.


Novorapid Side Effects Report #4617244-6
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.

Novorapid Side Effects Report #4764867-X
Novorapid side effect was reported by a Physician from JAPAN on Aug 31, 2005. Male patient, 53 years of age, weighting 108.0 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, hepatic function abnormal, malaise. Novorapid dosage: unknown. During the same period patient was treated with GLYBURIDE, SIGMART, PANTOSIN, PANALDINE, AMANTADINE, ACTOS, BASEN. Patient recovered.